Tags

Type your tag names separated by a space and hit enter

Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients.

Authors+Show Affiliations

AOU Careggi, Malattie Emorragiche e della Coagulazione, Firenze, Italy.Department of Haematology, S. Giovanni Battista Hospital, Turin, Italy.Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Foundation, Maggiore Hospital Policlinico, Milan, Italy.Department of Haematology, Haemophilia Centre, Castelfranco Veneto, Italy.Louis Turcanu', Louis Turcanu" Children Clinical Emergency Hospital, Timisoara, Romania.Fundeni Clinical Institute, Bucharest, Romania.Hematology Department, Country Emergency Hospital, Baia Mare, Romania.Surgery (QEII Medical Centre), The University of Western Australia (M509), Crawley, WA, Australia.Italian Association of Haemophilia Centres, Milan, Italy.

Pub Type(s)

Letter

Language

eng

PubMed ID

31509326

Citation

Castaman, Giancarlo, et al. "Pharmacokinetics of a New Human Plasma-derived Double Virus Inactivated and Nanofiltered Factor IX Concentrate in Previously Treated Severe or Moderately Severe Haemophilia B Patients." Haemophilia : the Official Journal of the World Federation of Hemophilia, 2019.
Castaman G, Borchiellini A, Santagostino E, et al. Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients. Haemophilia. 2019.
Castaman, G., Borchiellini, A., Santagostino, E., Tagariello, G., Serban, M., Uscatescu, M., ... Morfini, M. (2019). Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients. Haemophilia : the Official Journal of the World Federation of Hemophilia, doi:10.1111/hae.13828.
Castaman G, et al. Pharmacokinetics of a New Human Plasma-derived Double Virus Inactivated and Nanofiltered Factor IX Concentrate in Previously Treated Severe or Moderately Severe Haemophilia B Patients. Haemophilia. 2019 Sep 11; PubMed PMID: 31509326.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pharmacokinetics of a new human plasma-derived double virus inactivated and nanofiltered factor IX concentrate in previously treated severe or moderately severe haemophilia B patients. AU - Castaman,Giancarlo, AU - Borchiellini,Alessandra, AU - Santagostino,Elena, AU - Tagariello,Giuseppe, AU - Serban,Margit, AU - Uscatescu,Marusia, AU - Truica,Cristina, AU - Albert,Farrugia, AU - Morfini,Massimo, Y1 - 2019/09/11/ PY - 2019/04/13/received PY - 2019/07/01/revised PY - 2019/07/01/accepted PY - 2019/9/12/entrez JF - Haemophilia : the official journal of the World Federation of Hemophilia JO - Haemophilia SN - 1365-2516 UR - https://www.unboundmedicine.com/medline/citation/31509326/Pharmacokinetics_of_a_new_human_plasma-derived_double_virus_inactivated_and_nanofiltered_factor_IX_concentrate_in_previously_treated_severe_or_moderately_severe_haemophilia_B_patients L2 - https://doi.org/10.1111/hae.13828 DB - PRIME DP - Unbound Medicine ER -